E-Prescribing Market by Component (Solutions and Services), Deployment (On-premise and Cloud), and End User (Hospitals, Office-based Physicians, and Pharmaceuticals): Global Opportunity Analysis and Industry Forecast, 2019–2026
Electronic prescribing or e-prescribing is a digital application that securely provides bidirectional electronic information exchange between payers/PBMs, pharmacies, prescribing providers, directly or through an intermediary network. E-prescribing includes routing prescriptions that ensures prescribed drug against the patient’s health formulary of covered drugs, obtains prior authorization, gains any known patient drug allergies, identifiesany drug-drug interactions, provides access to patients’ medication history from external sources, and sends or receives acknowledgement of prescriptions filled. The major capability of e-prescribing is to support important process in care delivery, such as medication management, medication reconciliation, and prior authorization, this in turn is driving the e-prescribing market growth.
Factors that drive the growth of the global e-prescribing market include rise in focus of developed government initiatives and incentive programs toward adoption of e-prescribing solutions, rise in focus on the reduction of fraud and abuse of controlled substances, and increase in need to curtail escalating healthcare costs. However, e-prescribing solutions are costly to integrate in the EHR or HIT systems and rise in concerns associated with security & workflow of digital healthcare records are major factors that hinder the e-prescribing market growth. Furthermore, increase in development of healthcare infrastructure and rise in adoption of e-prescribing in the developing countries across Asia-Pacific are opportunistic factors of the global e-prescribing market.
The e-prescribingmarketis segmented on the basis of component,deployment,end user, and region. Bycomponent, it is categorized into solutionsand services.On the basis of deployment, it is divided on-premise and cloud. Depending on end user, it is classifiedinto hospitals, office-based physicians, and pharmaceuticals.By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The market players operating in the e-prescribing marketinclude Allscripts Healthcare, LLC, Athenahealth, Inc., Cerner Corporation, Change Healthcare, DrFirst.com, Inc., eClinicalWorks, Epic Systems Corporation, Medical Information Technology, Inc., Practice Fusion, Inc., and Surescripts.
KEY BENEFITS FOR STAKEHOLDERS
By Component
Factors that drive the growth of the global e-prescribing market include rise in focus of developed government initiatives and incentive programs toward adoption of e-prescribing solutions, rise in focus on the reduction of fraud and abuse of controlled substances, and increase in need to curtail escalating healthcare costs. However, e-prescribing solutions are costly to integrate in the EHR or HIT systems and rise in concerns associated with security & workflow of digital healthcare records are major factors that hinder the e-prescribing market growth. Furthermore, increase in development of healthcare infrastructure and rise in adoption of e-prescribing in the developing countries across Asia-Pacific are opportunistic factors of the global e-prescribing market.
The e-prescribingmarketis segmented on the basis of component,deployment,end user, and region. Bycomponent, it is categorized into solutionsand services.On the basis of deployment, it is divided on-premise and cloud. Depending on end user, it is classifiedinto hospitals, office-based physicians, and pharmaceuticals.By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The market players operating in the e-prescribing marketinclude Allscripts Healthcare, LLC, Athenahealth, Inc., Cerner Corporation, Change Healthcare, DrFirst.com, Inc., eClinicalWorks, Epic Systems Corporation, Medical Information Technology, Inc., Practice Fusion, Inc., and Surescripts.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the current & future trends of the market to elucidate the imminent investment pockets.
- Information about key drivers, restraints, and opportunities and their impact analysis on the global e-prescribing market size is provided.
- Porter’s five forces analysis illustrates the potency of the buyers and suppliers operating in the global e-prescribing industry.
- The quantitative analysis of the market from 2018 to 2026 is provided to determine the global e-prescribing market potential.
By Component
- Solutions
- Services
- On-premise
- Cloud
- Hospitals
- Office-based Physicians
- Pharmaceuticals
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
- Allscripts Healthcare, LLC
- Athenahealth, Inc.
- Cerner Corporation
- Change Healthcare
- DrFirst.com, Inc.
- eClinicalWorks
- Epic Systems Corporation
- Medical Information Technology, Inc.
- Practice Fusion, Inc.
- Surescripts
CHAPTER 1: INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. KEY MARKET PLAYERS
1.5. RESEARCH METHODOLOGY
1.5.1. Secondary research
1.5.2. Primary research
1.5.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS
2.1.1. Top impacting factors
2.1.2. Top investment pockets
2.2. CXO PERSPECTIVE
CHAPTER 3: MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FORCES SHAPING THE GLOBAL E-PRESCRIBING MARKET
3.3. VALUE CHAIN ANALYSIS
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Government initiatives and incentive programs
3.4.1.2. Rise in focus on the reduction of fraud and abuse of controlled substances
3.4.1.3. Need to curtail escalating healthcare costs
3.4.2. Restraints
3.4.2.1. High cost of systems
3.4.2.2. Security & workflow issues
3.4.3. Opportunities
3.4.3.1. Growth in the developing countries across Asia-Pacific
3.5. INDUSTRY ROADMAP OF E-PRESCRIBING
3.6. IMPACT OF GOVERNMENT REGULATIONS ON THE GLOBAL E-PRESCRIBING MARKET
CHAPTER 4: E-PRESCRIBING MARKET, BY COMPONENT
4.1. OVERVIEW
4.2. SOLUTIONS
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. SERVICES
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
CHAPTER 5: E-PRESCRIBING MARKET, BY DEPLOYMENT
5.1. OVERVIEW
5.2. WEB & CLOUD-BASED
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. ON-PREMISE
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
CHAPTER 6: E-PRESCRIBING MARKET, BY END USER
6.1. OVERVIEW
6.2. HOSPITALS
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.3. OFFICE-BASED PHYSICIANS
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.4. PHARMACEUTICALS
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country
CHAPTER 7: E-PRESCRIBING MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast, by region
7.2. NORTH AMERICA
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by component
7.2.3. Market size and forecast, by deployment
7.2.4. Market size and forecast, by end user
7.2.5. Market analysis, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by component
7.2.5.1.2. Market size and forecast, by deployment
7.2.5.1.3. Market size and forecast, by end user
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by component
7.2.5.2.2. Market size and forecast, by deployment
7.2.5.2.3. Market size and forecast, by end user
7.3. EUROPE
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by component
7.3.3. Market size and forecast, by deployment
7.3.4. Market size and forecast, by end user
7.3.5. Market analysis, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by component
7.3.5.1.2. Market size and forecast, by deployment
7.3.5.1.3. Market size and forecast, by end user
7.3.5.2. UK
7.3.5.2.1. Market size and forecast, by component
7.3.5.2.2. Market size and forecast, by deployment
7.3.5.2.3. Market size and forecast, by end user
7.3.5.3. France
7.3.5.3.1. Market size and forecast, by component
7.3.5.3.2. Market size and forecast, by deployment
7.3.5.3.3. Market size and forecast, by end user
7.3.5.4. Rest of Europe
7.3.5.4.1. Market size and forecast, by component
7.3.5.4.2. Market size and forecast, by deployment
7.3.5.4.3. Market size and forecast, by end user
7.4. ASIA-PACIFIC
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by component
7.4.3. Market size and forecast, by deployment
7.4.4. Market size and forecast, by end user
7.4.5. Market analysis, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by component
7.4.5.1.2. Market size and forecast, by deployment
7.4.5.1.3. Market size and forecast, by end user
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by component
7.4.5.2.2. Market size and forecast, by deployment
7.4.5.2.3. Market size and forecast, by end user
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by component
7.4.5.3.2. Market size and forecast, by deployment
7.4.5.3.3. Market size and forecast, by end user
7.4.5.4. Rest of Asia-Pacific
7.4.5.4.1. Market size and forecast, by component
7.4.5.4.2. Market size and forecast, by deployment
7.4.5.4.3. Market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by component
7.5.3. Market size and forecast, by deployment
7.5.4. Market size and forecast, by end user
7.5.5. Market analysis, by country
7.5.5.1. Latin America
7.5.5.1.1. Market size and forecast, by component
7.5.5.1.2. Market size and forecast, by deployment
7.5.5.1.3. Market size and forecast, by end user
7.5.5.2. Middle East
7.5.5.2.1. Market size and forecast, by component
7.5.5.2.2. Market size and forecast, by deployment
7.5.5.2.3. Market size and forecast, by end user
7.5.5.3. Africa
7.5.5.3.1. Market size and forecast, by component
7.5.5.3.2. Market size and forecast, by deployment
7.5.5.3.3. Market size and forecast, by end user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. KEY PLAYERS POSITIONING ANALYSIS, 2018
8.2. TOP WINNING STRATEGIES
8.3. KEY DEVELOPMENTS
8.3.1. Product launches
8.3.2. Partnership
8.3.3. Business expansion
8.3.4. Acquisition
8.3.5. Collaboration
8.4. PATENT ANALYSIS
8.4.1. By region (2016-2019)
8.4.2. By applicant
CHAPTER 9: COMPANY PROFILE
9.1. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. R&D Expenditure
9.1.7. Business performance
9.1.8. Key strategic moves and developments
9.2. ATHENAHEALTH, INC.
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Product portfolio
9.2.5. Key strategic moves and developments
9.3. CERNER CORPORATION
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments
9.4. CHANGE HEALTHCARE
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Product portfolio
9.4.5. Key strategic moves and developments
9.5. DRFIRST
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Product portfolio
9.5.5. Key strategic moves and developments
9.6. ECLINICALWORKS
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Product portfolio
9.6.5. Key strategic moves and developments
9.7. EPIC SYSTEMS CORPORATION
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Product portfolio
9.7.5. Key strategic moves and developments
9.8. MEDICAL INFORMATION TECHNOLOGY, INC.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Product portfolio
9.8.5. Key strategic moves and developments
9.9. PRACTICE FUSION, INC.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Product portfolio
9.9.5. Key strategic moves and developments
9.10. SURESCRIPTS
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Product portfolio
9.10.5. Key strategic moves and developments
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. KEY MARKET PLAYERS
1.5. RESEARCH METHODOLOGY
1.5.1. Secondary research
1.5.2. Primary research
1.5.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS
2.1.1. Top impacting factors
2.1.2. Top investment pockets
2.2. CXO PERSPECTIVE
CHAPTER 3: MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FORCES SHAPING THE GLOBAL E-PRESCRIBING MARKET
3.3. VALUE CHAIN ANALYSIS
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Government initiatives and incentive programs
3.4.1.2. Rise in focus on the reduction of fraud and abuse of controlled substances
3.4.1.3. Need to curtail escalating healthcare costs
3.4.2. Restraints
3.4.2.1. High cost of systems
3.4.2.2. Security & workflow issues
3.4.3. Opportunities
3.4.3.1. Growth in the developing countries across Asia-Pacific
3.5. INDUSTRY ROADMAP OF E-PRESCRIBING
3.6. IMPACT OF GOVERNMENT REGULATIONS ON THE GLOBAL E-PRESCRIBING MARKET
CHAPTER 4: E-PRESCRIBING MARKET, BY COMPONENT
4.1. OVERVIEW
4.2. SOLUTIONS
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. SERVICES
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
CHAPTER 5: E-PRESCRIBING MARKET, BY DEPLOYMENT
5.1. OVERVIEW
5.2. WEB & CLOUD-BASED
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. ON-PREMISE
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
CHAPTER 6: E-PRESCRIBING MARKET, BY END USER
6.1. OVERVIEW
6.2. HOSPITALS
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.3. OFFICE-BASED PHYSICIANS
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.4. PHARMACEUTICALS
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country
CHAPTER 7: E-PRESCRIBING MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast, by region
7.2. NORTH AMERICA
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by component
7.2.3. Market size and forecast, by deployment
7.2.4. Market size and forecast, by end user
7.2.5. Market analysis, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by component
7.2.5.1.2. Market size and forecast, by deployment
7.2.5.1.3. Market size and forecast, by end user
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by component
7.2.5.2.2. Market size and forecast, by deployment
7.2.5.2.3. Market size and forecast, by end user
7.3. EUROPE
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by component
7.3.3. Market size and forecast, by deployment
7.3.4. Market size and forecast, by end user
7.3.5. Market analysis, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by component
7.3.5.1.2. Market size and forecast, by deployment
7.3.5.1.3. Market size and forecast, by end user
7.3.5.2. UK
7.3.5.2.1. Market size and forecast, by component
7.3.5.2.2. Market size and forecast, by deployment
7.3.5.2.3. Market size and forecast, by end user
7.3.5.3. France
7.3.5.3.1. Market size and forecast, by component
7.3.5.3.2. Market size and forecast, by deployment
7.3.5.3.3. Market size and forecast, by end user
7.3.5.4. Rest of Europe
7.3.5.4.1. Market size and forecast, by component
7.3.5.4.2. Market size and forecast, by deployment
7.3.5.4.3. Market size and forecast, by end user
7.4. ASIA-PACIFIC
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by component
7.4.3. Market size and forecast, by deployment
7.4.4. Market size and forecast, by end user
7.4.5. Market analysis, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by component
7.4.5.1.2. Market size and forecast, by deployment
7.4.5.1.3. Market size and forecast, by end user
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by component
7.4.5.2.2. Market size and forecast, by deployment
7.4.5.2.3. Market size and forecast, by end user
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by component
7.4.5.3.2. Market size and forecast, by deployment
7.4.5.3.3. Market size and forecast, by end user
7.4.5.4. Rest of Asia-Pacific
7.4.5.4.1. Market size and forecast, by component
7.4.5.4.2. Market size and forecast, by deployment
7.4.5.4.3. Market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by component
7.5.3. Market size and forecast, by deployment
7.5.4. Market size and forecast, by end user
7.5.5. Market analysis, by country
7.5.5.1. Latin America
7.5.5.1.1. Market size and forecast, by component
7.5.5.1.2. Market size and forecast, by deployment
7.5.5.1.3. Market size and forecast, by end user
7.5.5.2. Middle East
7.5.5.2.1. Market size and forecast, by component
7.5.5.2.2. Market size and forecast, by deployment
7.5.5.2.3. Market size and forecast, by end user
7.5.5.3. Africa
7.5.5.3.1. Market size and forecast, by component
7.5.5.3.2. Market size and forecast, by deployment
7.5.5.3.3. Market size and forecast, by end user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. KEY PLAYERS POSITIONING ANALYSIS, 2018
8.2. TOP WINNING STRATEGIES
8.3. KEY DEVELOPMENTS
8.3.1. Product launches
8.3.2. Partnership
8.3.3. Business expansion
8.3.4. Acquisition
8.3.5. Collaboration
8.4. PATENT ANALYSIS
8.4.1. By region (2016-2019)
8.4.2. By applicant
CHAPTER 9: COMPANY PROFILE
9.1. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. R&D Expenditure
9.1.7. Business performance
9.1.8. Key strategic moves and developments
9.2. ATHENAHEALTH, INC.
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Product portfolio
9.2.5. Key strategic moves and developments
9.3. CERNER CORPORATION
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments
9.4. CHANGE HEALTHCARE
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Product portfolio
9.4.5. Key strategic moves and developments
9.5. DRFIRST
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Product portfolio
9.5.5. Key strategic moves and developments
9.6. ECLINICALWORKS
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Product portfolio
9.6.5. Key strategic moves and developments
9.7. EPIC SYSTEMS CORPORATION
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Product portfolio
9.7.5. Key strategic moves and developments
9.8. MEDICAL INFORMATION TECHNOLOGY, INC.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Product portfolio
9.8.5. Key strategic moves and developments
9.9. PRACTICE FUSION, INC.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Product portfolio
9.9.5. Key strategic moves and developments
9.10. SURESCRIPTS
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Product portfolio
9.10.5. Key strategic moves and developments
LIST OF TABLES
TABLE 01. E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
TABLE 02. E-PRESCRIBING MARKET REVENUE FOR SOLUTIONS, BY REGION 2018–2026 ($MILLION)
TABLE 03. E-PRESCRIBING MARKET REVENUE FOR SERVICES, BY REGION 2018–2026 ($MILLION)
TABLE 04. E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 05. E-PRESCRIBING MARKET REVENUE FOR WEB & CLOUD-BASED, BY REGION 2018–2026 ($MILLION)
TABLE 06. E-PRESCRIBING MARKET REVENUE FOR ON-PREMISE, BY REGION 2018–2026 ($MILLION)
TABLE 07. GLOBAL E-PRESCRIBING MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 08. E-PRESCRIBING MARKET REVENUE FOR HOSPITALS, BY REGION, 2018–2026 ($MILLION)
TABLE 09. E-PRESCRIBING MARKET REVENUE FOR OFFICE-BASED PHYSICIANS, BY REGION, 2018–2026 ($MILLION)
TABLE 10. E-PRESCRIBING MARKET REVENUE FOR PHARMACEUTICALS, BY REGION, 2018–2026 ($MILLION)
TABLE 11. GLOBAL E-PRESCRIBING MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
TABLE 12. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 13. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018–2026 ($MILLION)
TABLE 14. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 15. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 16. U.S. E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 17. U.S. E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 18. U.S. E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 19. CANADA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 20. CANADA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 21. CANADA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 22. EUROPE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 23. EUROPE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018–2026 ($MILLION)
TABLE 24. EUROPE E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 25. EUROPE E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 26. GERMANY E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 27. GERMANY E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 28. GERMANY E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 29. UK E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 30. UK E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 31. UK E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 32. FRANCE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 33. FRANCE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 34. FRANCE E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 35. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 36. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 37. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 38. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 39. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018–2026 ($MILLION)
TABLE 40. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 41. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 42. JAPAN E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 43. JAPAN E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 44. JAPAN E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 45. CHINA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 46. CHINA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 47. CHINA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 48. INDIA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 49. INDIA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 50. INDIA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 51. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 52. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 53. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 54. LAMEA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 55. LAMEA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018–2026 ($MILLION)
TABLE 56. LAMEA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 57. LAMEA E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 58. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 59. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 60. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 61. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 62. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 63. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 64. AFRICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 65. AFRICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 66. AFRICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 67. KEY NEW PRODUCT LAUNCHES (2016-2019)
TABLE 68. PARTNERSHIP (2016-2019)
TABLE 69. KEY EXPANSION (2016-2019)
TABLE 70. KEY ACQUISITION (2016-2019)
TABLE 71. COLLABORATION (2016-2019)
TABLE 72. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: KEY EXECUTIVES
TABLE 73. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT
TABLE 74. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: OPERATING SEGMENTS
TABLE 75. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: PRODUCT PORTFOLIO
TABLE 76. ATHENAHEALTH, INC.: KEY EXECUTIVES
TABLE 77. ATHENAHEALTH, INC.: COMPANY SNAPSHOT
TABLE 78. ATHENAHEALTH, INC.: PRODUCT PORTFOLIO
TABLE 79. CERNER CORPORATION: KEY EXECUTIVES
TABLE 80. CERNER CORPORATION: COMPANY SNAPSHOT
TABLE 81. CERNER CORPORATION: PRODUCT PORTFOLIO
TABLE 82. CHANGE HEALTHCARE: KEY EXECUTIVES
TABLE 83. CHANGE HEALTHCARE: COMPANY SNAPSHOT
TABLE 84. CHANGE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 85. DRFIRST: KEY EXECUTIVES
TABLE 86. DRFIRST: COMPANY SNAPSHOT
TABLE 87. DRFIRST: PRODUCT PORTFOLIO
TABLE 88. ECLINICALWORKS: KEY EXECUTIVES
TABLE 89. ECLINICALWORKS: COMPANY SNAPSHOT
TABLE 90. ECLINICALWORKS: PRODUCT PORTFOLIO
TABLE 91. EPIC SYSTEMS CORPORATION: KEY EXECUTIVES
TABLE 92. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
TABLE 93. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 94. MEDICAL INFORMATION TECHNOLOGY, INC.: KEY EXECUTIVES
TABLE 95. MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY SNAPSHOT
TABLE 96. MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCT PORTFOLIO
TABLE 97. PRACTICE FUSION, INC.: KEY EXECUTIVES
TABLE 98. PRACTICE FUSION, INC.: COMPANY SNAPSHOT
TABLE 99. PRACTICE FUSION, INC.: PRODUCT PORTFOLIO
TABLE 100. SURESCRIPTS: KEY EXECUTIVES
TABLE 101. SURESCRIPTS: COMPANY SNAPSHOT
TABLE 102. SURESCRIPTS: PRODUCT PORTFOLIO
TABLE 01. E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
TABLE 02. E-PRESCRIBING MARKET REVENUE FOR SOLUTIONS, BY REGION 2018–2026 ($MILLION)
TABLE 03. E-PRESCRIBING MARKET REVENUE FOR SERVICES, BY REGION 2018–2026 ($MILLION)
TABLE 04. E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 05. E-PRESCRIBING MARKET REVENUE FOR WEB & CLOUD-BASED, BY REGION 2018–2026 ($MILLION)
TABLE 06. E-PRESCRIBING MARKET REVENUE FOR ON-PREMISE, BY REGION 2018–2026 ($MILLION)
TABLE 07. GLOBAL E-PRESCRIBING MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 08. E-PRESCRIBING MARKET REVENUE FOR HOSPITALS, BY REGION, 2018–2026 ($MILLION)
TABLE 09. E-PRESCRIBING MARKET REVENUE FOR OFFICE-BASED PHYSICIANS, BY REGION, 2018–2026 ($MILLION)
TABLE 10. E-PRESCRIBING MARKET REVENUE FOR PHARMACEUTICALS, BY REGION, 2018–2026 ($MILLION)
TABLE 11. GLOBAL E-PRESCRIBING MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
TABLE 12. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 13. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018–2026 ($MILLION)
TABLE 14. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 15. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 16. U.S. E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 17. U.S. E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 18. U.S. E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 19. CANADA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 20. CANADA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 21. CANADA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 22. EUROPE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 23. EUROPE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018–2026 ($MILLION)
TABLE 24. EUROPE E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 25. EUROPE E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 26. GERMANY E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 27. GERMANY E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 28. GERMANY E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 29. UK E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 30. UK E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 31. UK E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 32. FRANCE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 33. FRANCE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 34. FRANCE E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 35. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 36. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 37. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 38. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 39. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018–2026 ($MILLION)
TABLE 40. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 41. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 42. JAPAN E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 43. JAPAN E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 44. JAPAN E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 45. CHINA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 46. CHINA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 47. CHINA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 48. INDIA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 49. INDIA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 50. INDIA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 51. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 52. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 53. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 54. LAMEA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 55. LAMEA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018–2026 ($MILLION)
TABLE 56. LAMEA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 57. LAMEA E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 58. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 59. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 60. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 61. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 62. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 63. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 64. AFRICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 65. AFRICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 66. AFRICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 67. KEY NEW PRODUCT LAUNCHES (2016-2019)
TABLE 68. PARTNERSHIP (2016-2019)
TABLE 69. KEY EXPANSION (2016-2019)
TABLE 70. KEY ACQUISITION (2016-2019)
TABLE 71. COLLABORATION (2016-2019)
TABLE 72. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: KEY EXECUTIVES
TABLE 73. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT
TABLE 74. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: OPERATING SEGMENTS
TABLE 75. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: PRODUCT PORTFOLIO
TABLE 76. ATHENAHEALTH, INC.: KEY EXECUTIVES
TABLE 77. ATHENAHEALTH, INC.: COMPANY SNAPSHOT
TABLE 78. ATHENAHEALTH, INC.: PRODUCT PORTFOLIO
TABLE 79. CERNER CORPORATION: KEY EXECUTIVES
TABLE 80. CERNER CORPORATION: COMPANY SNAPSHOT
TABLE 81. CERNER CORPORATION: PRODUCT PORTFOLIO
TABLE 82. CHANGE HEALTHCARE: KEY EXECUTIVES
TABLE 83. CHANGE HEALTHCARE: COMPANY SNAPSHOT
TABLE 84. CHANGE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 85. DRFIRST: KEY EXECUTIVES
TABLE 86. DRFIRST: COMPANY SNAPSHOT
TABLE 87. DRFIRST: PRODUCT PORTFOLIO
TABLE 88. ECLINICALWORKS: KEY EXECUTIVES
TABLE 89. ECLINICALWORKS: COMPANY SNAPSHOT
TABLE 90. ECLINICALWORKS: PRODUCT PORTFOLIO
TABLE 91. EPIC SYSTEMS CORPORATION: KEY EXECUTIVES
TABLE 92. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
TABLE 93. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 94. MEDICAL INFORMATION TECHNOLOGY, INC.: KEY EXECUTIVES
TABLE 95. MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY SNAPSHOT
TABLE 96. MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCT PORTFOLIO
TABLE 97. PRACTICE FUSION, INC.: KEY EXECUTIVES
TABLE 98. PRACTICE FUSION, INC.: COMPANY SNAPSHOT
TABLE 99. PRACTICE FUSION, INC.: PRODUCT PORTFOLIO
TABLE 100. SURESCRIPTS: KEY EXECUTIVES
TABLE 101. SURESCRIPTS: COMPANY SNAPSHOT
TABLE 102. SURESCRIPTS: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. KEY MARKET SEGMENTS
FIGURE 02. GLOBAL E-PRESCRIBING MARKET, 2018–2026
FIGURE 03. GLOBAL E-PRESCRIBING MARKET, BY REGION, 2018–2026
FIGURE 04. TOP IMPACTING FACTORS
FIGURE 05. TOP INVESTMENT POCKETS
FIGURE 06. TOP PLAYERS OF THE GLOBAL E-PRESCRIBING MARKET
FIGURE 07. MODERATE-TO-HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 08. MODERATE-TO-HIGH BARGAINING POWER OF BUYER
FIGURE 09. MODERATE-TO-HIGH THREAT OF SUBSTITUTES
FIGURE 10. MODERATE-TO-HIGH THREAT OF NEW ENTRANTS
FIGURE 11. LOW-TO-HIGH COMPETITIVE RIVALRY
FIGURE 12. VALUE CHAIN ANALYSIS OF E-PRESCRIBING MARKET
FIGURE 13. MARKET DYNAMICS: GLOBAL E-PRESCRIBING MARKET
FIGURE 14. INDUSTRY ROADMAP OF E-PRESCRIBING
FIGURE 15. GLOBAL E-PRESCRIBING MARKET, BY COMPONENT, 2018-2026
FIGURE 16. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR SOLUTIONS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR SERVICES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18. GLOBAL E-PRESCRIBING MARKET, BY DEPLOYMENT, 2018–2025
FIGURE 19. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR WEB & CLOUD-BASED, BY COUNTRY, 2018 & 2026 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR ON-PREMISE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 21. GLOBAL E-PRESCRIBING MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR OFFICE-BASED PHYSICIANS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 25. GLOBAL E-PRESCRIBING MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
FIGURE 26. U.S. E-PRESCRIBING MARKET REVENUE, 2018–2026 ($MILLION)
FIGURE 27. CANADA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 28. GERMANY E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 29. UK E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 30. FRANCE E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 31. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 32. JAPAN E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 33. CHINA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 34. INDIA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 35. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 36. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 37. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 38. AFRICA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 39. KEY PLAYER POSITIONING ANLYSIS: GLOBAL E-PRESCRIBING MARKET
FIGURE 40. TOP WINNING STRATEGIES, BY YEAR, 2016-2019
FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2019
FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY, 2016-2019
FIGURE 43. PATENT ANALYSIS, BY REGION
FIGURE 44. PATENT ANALYSIS, BY APPLICANT
FIGURE 45. R&D EXPENDITURE, 2016–2018 ($MILLION)
FIGURE 46. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE, 2016–2018 ($MILLION)
FIGURE 47. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 49. CERNER CORPORATION: REVENUE, 2016–2018 ($MILLION)
FIGURE 50. CERNER CORPORATION: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 01. KEY MARKET SEGMENTS
FIGURE 02. GLOBAL E-PRESCRIBING MARKET, 2018–2026
FIGURE 03. GLOBAL E-PRESCRIBING MARKET, BY REGION, 2018–2026
FIGURE 04. TOP IMPACTING FACTORS
FIGURE 05. TOP INVESTMENT POCKETS
FIGURE 06. TOP PLAYERS OF THE GLOBAL E-PRESCRIBING MARKET
FIGURE 07. MODERATE-TO-HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 08. MODERATE-TO-HIGH BARGAINING POWER OF BUYER
FIGURE 09. MODERATE-TO-HIGH THREAT OF SUBSTITUTES
FIGURE 10. MODERATE-TO-HIGH THREAT OF NEW ENTRANTS
FIGURE 11. LOW-TO-HIGH COMPETITIVE RIVALRY
FIGURE 12. VALUE CHAIN ANALYSIS OF E-PRESCRIBING MARKET
FIGURE 13. MARKET DYNAMICS: GLOBAL E-PRESCRIBING MARKET
FIGURE 14. INDUSTRY ROADMAP OF E-PRESCRIBING
FIGURE 15. GLOBAL E-PRESCRIBING MARKET, BY COMPONENT, 2018-2026
FIGURE 16. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR SOLUTIONS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR SERVICES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18. GLOBAL E-PRESCRIBING MARKET, BY DEPLOYMENT, 2018–2025
FIGURE 19. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR WEB & CLOUD-BASED, BY COUNTRY, 2018 & 2026 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR ON-PREMISE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 21. GLOBAL E-PRESCRIBING MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR OFFICE-BASED PHYSICIANS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 25. GLOBAL E-PRESCRIBING MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
FIGURE 26. U.S. E-PRESCRIBING MARKET REVENUE, 2018–2026 ($MILLION)
FIGURE 27. CANADA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 28. GERMANY E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 29. UK E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 30. FRANCE E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 31. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 32. JAPAN E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 33. CHINA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 34. INDIA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 35. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 36. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 37. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 38. AFRICA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 39. KEY PLAYER POSITIONING ANLYSIS: GLOBAL E-PRESCRIBING MARKET
FIGURE 40. TOP WINNING STRATEGIES, BY YEAR, 2016-2019
FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2019
FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY, 2016-2019
FIGURE 43. PATENT ANALYSIS, BY REGION
FIGURE 44. PATENT ANALYSIS, BY APPLICANT
FIGURE 45. R&D EXPENDITURE, 2016–2018 ($MILLION)
FIGURE 46. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE, 2016–2018 ($MILLION)
FIGURE 47. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 49. CERNER CORPORATION: REVENUE, 2016–2018 ($MILLION)
FIGURE 50. CERNER CORPORATION: REVENUE SHARE BY REGION, 2018 (%)
